Bitcoin fell 2.3% over the past week to $83,876.47 as higher U.S. Treasury yields and declines in major stock indexes pressured risk assets. The 10-year Treasury yield hit 5.27% before closing at 5.23%, following the Federal Reserve's recent rate hike and ongoing inflation concerns. Despite the pullback, U.S. spot Bitcoin ETFs saw net inflows of about $2.39 billion from Sept. 21 to 25, though daily inflows slowed over the period. This suggests a market correction after strong ETF buying, but no clear shift away from Bitcoin investment products yet.
Bitcoin's recent market context includes a 10-year U.S. Treasury yield closing at 5.23%, with Bitcoin itself down 2.3% over the past week to $83,876.47. For readers following cryptocurrency trends, here is Pluang's market snapshot as of Sep 29, 2026 16:02 WIB: out of 50 major cryptocurrencies priced, 33 rose and 15 fell today. Notable movers include LINK (Chainlink) up 12.00% at Rp274.793 with a typical hold time of 63 days and a 40% sell / 60% buy order activity, BAL (Balancer) up 11.14% at Rp16.297 with a typical hold time of 85 days, and ONE (Harmony) down 10.79% at Rp42 with a typical hold time of 152 days and 34% sell / 66% buy order activity.
Solana (SOL) price fell about 1.6% to $116.95 on Sept. 29 after nearing $125 over the weekend, marking a second day of decline following a strong September recovery from below $100. The $120 level is critical, having been briefly surpassed but not ye...
BFA Law is investigating Lululemon for potential securities fraud after the company's stock fell sharply due to concerns about its growth and business health. Key stock drops occurred following announcements about a new CEO appointment, declining gro...
BFA Law is investigating the $8.05 per share take-private acquisition of Priority Technology Holdings by its controlling shareholder Thomas Priore. The law firm is examining whether the deal terms and approval process fairly protect minority sharehol...
BFA Law is investigating Medline Inc. for potential securities fraud related to misleading statements about its manufacturing and product quality. The investigation follows significant stock declines after the FDA issued a warning about Medline's vio...
Avalanche (AVAX) surged 8.77% over four hours to reach $11.60, extending its 24-hour gain to 11.08%. The price increase was recorded on Binance’s AVAX/USDT spot market, pushing AVAX's market cap to about $4.99 billion, ranking it 27th globally. Recen...
